Texas AG/Quest IV settlement
This article was originally published in The Tan Sheet
Executive Summary
Quest IV Health Products agrees to cease making unapproved drug claims, offer refunds to purchasers and pay the state $15,000 for attorneys' fees under a settlement announced April 20. The Arlington, Tex.-based firm had been claiming its Restores+ product was an effective treatment for ADD, ADHD, alcoholism and symptoms of the diseases. Caucasicum+ was marketed as a treatment for alcoholism, cancer and heart disease. The settlement was filed in a Dallas court April 19
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning